UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Differential diagnosis of suspected multiple sclerosis: a consensus approach

Multiple sclerosis, 2008-11, Vol.14 (9), p.1157-1174

2008

Volltextzugriff (PDF)

The role of magnetic resonance techniques in understanding and managing multiple sclerosis

Brain (London, England : 1878), 1998, Vol.121 (1), p.3-24

1998

Volltextzugriff (PDF)

Thalamic Involvement and Its Impact on Clinical Disability in Patients with Multiple Sclerosis: A Diffusion Tensor Imaging Study at 3T

American journal of neuroradiology : AJNR, 2009-08, Vol.30 (7), p.1380-1386

2009

Volltextzugriff (PDF)

Expression profiling identifies responder and non‐responder phenotypes to interferon‐β in multiple sclerosis

Brain (London, England : 1878), 2003-06, Vol.126 (6), p.1419-1429

2003

Volltextzugriff (PDF)

The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis

Neurology, 1999-08, Vol.53 (3), p.448-448

1999

Volltextzugriff (PDF)

MRI as a marker for disease heterogeneity in multiple sclerosis

Neurology, 2005-10, Vol.65 (7), p.1071-1076

2005

Volltextzugriff (PDF)

In Vivo Detection of Cortical Plaques by MR Imaging in Patients with Multiple Sclerosis

American Journal of Neuroradiology, 2006-11, Vol.27 (10), p.2161-2167

2006

Volltextzugriff (PDF)

Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses

Multiple sclerosis, 2008-07, Vol.14 (6), p.770-778

2008

Volltextzugriff (PDF)

Ring and nodular multiple sclerosis lesions: a retrospective natural history study

Neurology, 2010-03, Vol.74 (10), p.851-856

2010

Volltextzugriff (PDF)

Relationship between inflammatory lesions and cerebral atrophy in multiple sclerosis

Neurology, 2006-02, Vol.66 (4), p.551-556

2006

Volltextzugriff (PDF)

The role of MRI as a surrogate outcome measure in multiple sclerosis

Multiple sclerosis, 2002-02, Vol.8 (1), p.40-51

2002

Volltextzugriff (PDF)

Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS

Neurology, 1998-07, Vol.51 (1), p.289-292

1998

Volltextzugriff (PDF)

Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis

Annals of neurology, 1998-04, Vol.43 (4), p.499-506

1998

Volltextzugriff (PDF)

Immunological Aspects of Demyelinating Diseases

Annual review of immunology, 1992-01, Vol.10 (1), p.153-187

1992

Volltextzugriff (PDF)

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

Annals of neurology, 2001-07, Vol.50 (1), p.121-127

2001

Volltextzugriff (PDF)

VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta

Neurology, 1997-10, Vol.49 (4), p.1111-1116

1997

Volltextzugriff (PDF)

Characterization of MRI response to treatment with interferon beta-1b: contrast-enhancing MRI lesion frequency as a primary outcome measure

Neurology, 1997-09, Vol.49 (3), p.862-869

1997

Volltextzugriff (PDF)

Role of magnetic resonance imaging in the diagnosis and monitoring of multiple sclerosis: Consensus report of the White Matter Study Group

Journal of magnetic resonance imaging, 2002-05, Vol.15 (5), p.499-504

2002

Volltextzugriff (PDF)

Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients

Annals of neurology, 2000-03, Vol.47 (3), p.306-313

2000

Volltextzugriff (PDF)

Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis

Annals of neurology, 1993-11, Vol.34 (5), p.661-669

1993

Volltextzugriff (PDF)

Humanized Anti-CD25 (Daclizumab) Inhibits Disease Activity in Multiple Sclerosis Patients Failing to Respond to Interferon β

Proceedings of the National Academy of Sciences - PNAS, 2004-06, Vol.101 (23), p.8705-8708

2004

Volltextzugriff (PDF)

Molecular mimicry and multiple sclerosis: Degenerate T-cell recognition and the induction of autoimmunity

Annals of neurology, 1999-05, Vol.45 (5), p.559-567

1999

Volltextzugriff (PDF)

Complexities in the Treatment of Autoimmune Disease

Science (American Association for the Advancement of Science), 1996-12, Vol.274 (5295), p.2037-2038

McFarland, Henry F.

1996

Volltextzugriff (PDF)

Interferon beta results in immediate reduction of contrast-enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI

Neurology, 1997-05, Vol.48 (5), p.1446-1448

1997

Volltextzugriff (PDF)

Impaired renal function in progressive multiple sclerosis

Neurology, 2002-12, Vol.59 (11), p.1799-1801

2002

Volltextzugriff (PDF)

1 – 25 von 719

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(665)
Mit Volltextzugriff
(579)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Differential diagnosis of suspected multiple sclerosis: a consensus approach

The role of magnetic resonance techniques in understanding and managing multiple sclerosis

Thalamic Involvement and Its Impact on Clinical Disability in Patients with Multiple Sclerosis: A Diffusion Tensor Imaging Study at 3T

Expression profiling identifies responder and non‐responder phenotypes to interferon‐β in multiple sclerosis

The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis

MRI as a marker for disease heterogeneity in multiple sclerosis

In Vivo Detection of Cortical Plaques by MR Imaging in Patients with Multiple Sclerosis

Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses

Ring and nodular multiple sclerosis lesions: a retrospective natural history study

Relationship between inflammatory lesions and cerebral atrophy in multiple sclerosis

The role of MRI as a surrogate outcome measure in multiple sclerosis

Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS

Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis

Immunological Aspects of Demyelinating Diseases

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta

Characterization of MRI response to treatment with interferon beta-1b: contrast-enhancing MRI lesion frequency as a primary outcome measure

Role of magnetic resonance imaging in the diagnosis and monitoring of multiple sclerosis: Consensus report of the White Matter Study Group

Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients

Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis

Humanized Anti-CD25 (Daclizumab) Inhibits Disease Activity in Multiple Sclerosis Patients Failing to Respond to Interferon β

Molecular mimicry and multiple sclerosis: Degenerate T-cell recognition and the induction of autoimmunity

Complexities in the Treatment of Autoimmune Disease

Interferon beta results in immediate reduction of contrast-enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI

Impaired renal function in progressive multiple sclerosis

Suchergebnisse filtern